Chemotherapy of lung cancer: the experience of the National Cancer Institute of Milan.
作者信息
Bonadonna G, Tancini G, Bajetta E
出版信息
Cancer Chemother Rep 3. 1973 Mar;4(2):231-7.
PMID:4125741
Abstract
摘要
相似文献
1
Chemotherapy of lung cancer: the experience of the National Cancer Institute of Milan.
Cancer Chemother Rep 3. 1973 Mar;4(2):231-7.
2
[Prognostic factors in the chemotherapy of bronchial cancers].[支气管癌化疗中的预后因素]
Schweiz Med Wochenschr. 1974 Feb 23;104(8):268-71.
3
4
Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.六甲蜜胺、博来霉素和洛莫司汀对肺鳞状细胞癌、大细胞癌和腺癌患者进行化疗，这些患者对环磷酰胺、阿霉素、甲氨蝶呤和甲基苄肼无反应。
Cancer Treat Rep. 1978 Apr;62(4):567-9.
5
Clinical evaluation of procarbazine and fluorouracil in advanced lung cancer.
Bronches. 1971 Jul-Aug;21(4):402.
6
The role of chemotherapy in the treatment of lung cancer.化疗在肺癌治疗中的作用。
Semin Oncol. 1974 Sep;1(3):259-72.
7
The use of chemotherapy in lung cancer (controlled trials).
Med Ann Dist Columbia. 1971 Aug;40(8):489-95.
8
Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR.
Cancer Chemother Rep 3. 1973 Mar;4(2):251-5.
9
10
Monochemotherapy of bronchogenic carcinoma withs special reference to cell type.支气管源性癌的单一化学疗法，特别涉及细胞类型。
Cancer Chemother Rep 3. 1973 Mar;4(2):177-88.
Zotero 插件